Cuomo et al., 2015 - Google Patents
Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responsesCuomo et al., 2015
View PDF- Document ID
- 17380540555334076739
- Author
- Cuomo L
- Cirone M
- Di Gregorio A
- Vitillo M
- Cattivelli M
- Magliocca V
- Maiorano S
- Meledandri M
- Scagnolari C
- La Rocca S
- Trivedi P
- Publication year
- Publication venue
- Virus research
External Links
Snippet
It has been shown that Epstein-Barr virus (EBV) is able to alter the immune response towards self-antigens and may enhance risk of autoimmune diseases such as systemic lupus erythematosus (SLE) in genetically predisposed individuals. In this study, we …
- 230000028993 immune response 0 title abstract description 11
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guan et al. | The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to: in vivo: imaging | |
| Cuomo et al. | Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses | |
| Soldan et al. | Epstein–Barr virus and multiple sclerosis | |
| Lünemann et al. | Epstein-barr virus: environmental trigger of multiple sclerosis? | |
| Houldcroft et al. | Host genetics of Epstein–Barr virus infection, latency and disease | |
| Hussein et al. | The role of viral infections in the development of autoimmune diseases | |
| Moon et al. | Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood | |
| Meier et al. | Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis | |
| Esen et al. | Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study | |
| Aloisi et al. | Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy | |
| Wandinger et al. | Association between clinical disease activity and Epstein–Barr virus reactivation in MS | |
| White et al. | Immune modulation during latent herpesvirus infection | |
| Toussirot et al. | Pathophysiological links between rheumatoid arthritis and the Epstein–Barr virus: an update | |
| Ruprecht | The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review | |
| Vietzen et al. | Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis | |
| Poole et al. | Aberrant Epstein–Barr viral infection in systemic lupus erythematosus | |
| Pender | The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis | |
| Newkirk et al. | Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection | |
| Lu et al. | Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan | |
| Toussirot et al. | Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis | |
| Maślińska | The role of Epstein–Barr virus infection in primary Sjögren's syndrome | |
| Hedström | Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection | |
| Gerpe et al. | Distinctive EBV infection characteristics in children from a developing country | |
| Lünemann et al. | Epstein-Barr virus and multiple sclerosis | |
| Chang et al. | Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice |